{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T06:41:45Z","timestamp":1783233705735,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Young and middle-aged health science and technology innovation talent project of Henan Province","award":["YXKC2020037"],"award-info":[{"award-number":["YXKC2020037"]}]},{"name":"The Provincial and ministerial youth project and the Henan Medical Science and Technology Public Relations Program","award":["SB201902014"],"award-info":[{"award-number":["SB201902014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Given their widespread availability and relatively low cost, percutaneous thermal ablation is commonly performed under the guidance of computed tomography (CT) or ultrasound (US). However, such imaging modalities may be restricted due to insufficient image contrast and limited tumor visibility, which results in imperfect intraoperative treatment or an increased risk of damage to critical anatomical structures. Currently, magnetic resonance (MR) guidance has been proven to be a possible solution to overcome the above shortcomings, as it provides more reliable visualization of the target tumor and allows for multiplanar capabilities, making it the modality of choice. Unfortunately, MR-guided ablation is limited to specialized centers, and the cost is relatively high. Is ablation therapy under MR guidance better than that under CT guidance? This study retrospectively compared the efficacy of CT-guided and MR-guided microwave ablation (MWA) for the treatment of hepatocellular carcinoma (HCC\u2009\u2264\u20095.0\u2009cm).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, 47 patients and 54 patients received MWA under the guidance of CT and MR, respectively. The inclusion criteria were a single HCC\u2009\u2264\u20095.0\u2009cm or a maximum of three. The local tumor progression (LTP), overall survival (OS), prognostic factors for local progression, and safety of this technique were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All procedures were technically successful. The complication rates of the two groups were remarkably different with respect to incidences of liver abscess and pleural effusion (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The mean LTP was 44.264\u2009months in the CT-guided group versus 47.745\u2009months in the MR-guided group of HCC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.629, log-rank test). The mean OS was 56.772\u2009months in the patients who underwent the CT-guided procedure versus 58.123\u2009months in those who underwent the MR-guided procedure (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.630, log-rank test). Multivariate Cox regression analysis further illustrated that tumor diameter (&lt;\u20093\u2009cm) and the number of lesions (single) were important factors affecting LTP and OS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both CT-guided and MR-guided MWA are comparable therapies for the treatment of HCC (&lt;\u20095\u2009cm), and there was no difference in survival between the two groups. However, MR-guided MWA could reduce the incidence of complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08099-7","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T09:06:05Z","timestamp":1617786365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Image-guided microwave ablation of hepatocellular carcinoma (\u22645.0 cm): is MR guidance more effective than CT guidance?"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhaonan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-8619","authenticated-orcid":false,"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"8099_CR1","doi-asserted-by":"crossref","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. HEPATOLOGY 2020.","DOI":"10.1002\/hep.31288"},{"issue":"1","key":"8099_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35\u201343. https:\/\/doi.org\/10.1016\/S1470-2045(08)70284-5.","journal-title":"Lancet Oncol"},{"issue":"2","key":"8099_CR3","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.2217\/hep-2018-0001","volume":"5","author":"N Galanakis","year":"2018","unstructured":"Galanakis N, Kehagias E, Matthaiou N, et al. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepat Oncol. 2018;5(2):P7.","journal-title":"Hepat Oncol"},{"issue":"2","key":"8099_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3904\/kjim.2015.112","volume":"31","author":"MJ Song","year":"2016","unstructured":"Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, et al. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med. 2016;31(2):242\u201352. https:\/\/doi.org\/10.3904\/kjim.2015.112.","journal-title":"Korean J Intern Med"},{"issue":"12","key":"8099_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1111\/liv.14258","volume":"39","author":"HH Chu","year":"2019","unstructured":"Chu HH, Kim JH, Kim PN, Kim SY, Lim YS, Park SH, et al. Surgical resection versus radiofrequency ablation very early-stage HCC (<\/=2 cm single HCC): a propensity score analysis. Liver Int. 2019;39(12):2397\u2013407. https:\/\/doi.org\/10.1111\/liv.14258.","journal-title":"Liver Int"},{"issue":"1","key":"8099_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40644-020-0294-5","volume":"20","author":"Z Li","year":"2020","unstructured":"Li Z, Jiao D, Han X, Si G, Li Y, Liu J, et al. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging. 2020;20(1):13. https:\/\/doi.org\/10.1186\/s40644-020-0294-5.","journal-title":"Cancer Imaging"},{"issue":"8","key":"8099_CR7","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/j.1572-0241.2000.02275.x","volume":"95","author":"M Sato","year":"2000","unstructured":"Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am J Gastroenterol. 2000;95(8):2102\u20136. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02275.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"8099_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/02656736.2020.1736649","volume":"37","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang L, Li Y, Wang W. Computed tomography-guided percutaneous microwave ablation with artificial ascites for problematic hepatocellular tumors. Int J Hyperth. 2020;37(1):256\u201362. https:\/\/doi.org\/10.1080\/02656736.2020.1736649.","journal-title":"Int J Hyperth"},{"issue":"22","key":"8099_CR9","first-page":"5182","volume":"117","author":"X Li","year":"2011","unstructured":"Li X, Fan W, Zhang L, et al. CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results. Cancer-Am Cancer Soc. 2011;117(22):5182\u20138.","journal-title":"Cancer-Am Cancer Soc"},{"issue":"8","key":"8099_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","volume":"7","author":"JD Yang","year":"2010","unstructured":"Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448\u201358. https:\/\/doi.org\/10.1038\/nrgastro.2010.100.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8099_CR11","doi-asserted-by":"publisher","unstructured":"EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","DOI":"10.1016\/j.jhep.2018.03.019"},{"issue":"2","key":"8099_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u201350. https:\/\/doi.org\/10.1002\/hep.29913.","journal-title":"Hepatology"},{"issue":"10","key":"8099_CR13","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1634\/theoncologist.2018-0337","volume":"24","author":"F Izzo","year":"2019","unstructured":"Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24(10):e990\u20131005. https:\/\/doi.org\/10.1634\/theoncologist.2018-0337.","journal-title":"Oncologist"},{"issue":"5","key":"8099_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S2468-1253(18)30029-3","volume":"3","author":"VN Vietti","year":"2018","unstructured":"Vietti VN, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317\u201325. https:\/\/doi.org\/10.1016\/S2468-1253(18)30029-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"8099_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/02656736.2015.1127434","volume":"32","author":"A Facciorusso","year":"2016","unstructured":"Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperth. 2016;32(3):339\u201344. https:\/\/doi.org\/10.3109\/02656736.2015.1127434.","journal-title":"Int J Hyperth"},{"issue":"6","key":"8099_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/apt.14929","volume":"48","author":"W Liu","year":"2018","unstructured":"Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, et al. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Aliment Pharmacol Ther. 2018;48(6):671\u201381. https:\/\/doi.org\/10.1111\/apt.14929.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"8099_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.surg.2019.05.007","volume":"166","author":"T Ryu","year":"2019","unstructured":"Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma <\/=5 cm: a propensity score-matched analysis. SURGERY. 2019;166(3):254\u201362. https:\/\/doi.org\/10.1016\/j.surg.2019.05.007.","journal-title":"SURGERY"},{"key":"8099_CR18","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.2147\/OTT.S141968","volume":"10","author":"M Zhang","year":"2017","unstructured":"Zhang M, Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis. Onco Targets Ther. 2017;10:4829\u201339. https:\/\/doi.org\/10.2147\/OTT.S141968.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"8099_CR19","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s00330-012-2438-x","volume":"22","author":"H Rempp","year":"2012","unstructured":"Rempp H, Waibel L, Hoffmann R, Claussen CD, Pereira PL, Clasen S. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol. 2012;22(9):1972\u201382. https:\/\/doi.org\/10.1007\/s00330-012-2438-x.","journal-title":"Eur Radiol"},{"issue":"Suppl 1","key":"8099_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000315239","volume":"78","author":"M Kudo","year":"2010","unstructured":"Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78(Suppl 1):113\u201324. https:\/\/doi.org\/10.1159\/000315239.","journal-title":"Oncology"},{"issue":"1","key":"8099_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11605-007-0276-y","volume":"12","author":"KK Ng","year":"2008","unstructured":"Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg. 2008;12(1):183\u201391. https:\/\/doi.org\/10.1007\/s11605-007-0276-y.","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"8099_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.dld.2014.07.012","volume":"46","author":"A Facciorusso","year":"2014","unstructured":"Facciorusso A, Del PV, Antonino M, et al. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Dig Liver Dis. 2014;46(11):1014\u20139. https:\/\/doi.org\/10.1016\/j.dld.2014.07.012.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"8099_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jmri.26252","volume":"49","author":"J Weiss","year":"2019","unstructured":"Weiss J, Hoffmann R, Rempp H, Ke\u03b2ler DE, Pereira PL, Nikolaou K, et al. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (<\/=12 mm) hepatic malignancies. J Magn Reson Imaging. 2019;49(2):374\u201381. https:\/\/doi.org\/10.1002\/jmri.26252.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"8099_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1080\/02656736.2019.1690166","volume":"36","author":"Z Lin","year":"2019","unstructured":"Lin Z, Chen J, Yan Y, Chen J, Li Y. Microwave ablation of hepatic malignant tumors using 1.5T MRI guidance and monitoring: feasibility and preliminary clinical experience. Int J Hyperth. 2019;36(1):1216\u201322. https:\/\/doi.org\/10.1080\/02656736.2019.1690166.","journal-title":"Int J Hyperth"},{"issue":"1","key":"8099_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40644-020-00316-z","volume":"20","author":"MT Winkelmann","year":"2020","unstructured":"Winkelmann MT, Archid R, Gohla G, Hefferman G, K\u00fcbler J, Weiss J, et al. MRI-guided percutaneous thermoablation in combination with hepatic resection as parenchyma-sparing approach in patients with primary and secondary hepatic malignancies: single center long-term experience. Cancer Imaging. 2020;20(1):37. https:\/\/doi.org\/10.1186\/s40644-020-00316-z.","journal-title":"Cancer Imaging"},{"issue":"1","key":"8099_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/02656736.2020.1750713","volume":"37","author":"J Weiss","year":"2020","unstructured":"Weiss J, Winkelmann MT, Gohla G, K\u00fcbler J, Clasen S, Nikolaou K, et al. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperth. 2020;37(1):349\u201355. https:\/\/doi.org\/10.1080\/02656736.2020.1750713.","journal-title":"Int J Hyperth"},{"issue":"5","key":"8099_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4103\/jcrt.JCRT_1_20","volume":"16","author":"N Yang","year":"2020","unstructured":"Yang N, Gong J, Yao L, Wang C, Chen J, Liu J, et al. Magnetic resonance imaging-guided microwave ablation of hepatic malignancies: feasibility, efficacy, safety, and follow-up. J Cancer Res Ther. 2020;16(5):1151\u20136. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1_20.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"8099_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejrad.2013.09.018","volume":"83","author":"S Clasen","year":"2014","unstructured":"Clasen S, Rempp H, Hoffmann R, Graf H, Pereira PL, Claussen CD. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111\u20136. https:\/\/doi.org\/10.1016\/j.ejrad.2013.09.018.","journal-title":"Eur J Radiol"},{"issue":"8","key":"8099_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.hpb.2020.01.008","volume":"22","author":"C Chong","year":"2020","unstructured":"Chong C, Lee KF, Cheung S, et al. Prospective double-blinded randomized controlled trial of microwave versus RadioFrequency ablation for hepatocellular carcinoma (McRFA trial). HPB (Oxford). 2020;22(8):1121\u20137. https:\/\/doi.org\/10.1016\/j.hpb.2020.01.008.","journal-title":"HPB (Oxford)"},{"key":"8099_CR30","doi-asserted-by":"crossref","unstructured":"Facciorusso A, Abd EAM, Tartaglia N, et al. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Cancers (Basel). 2020:12.","DOI":"10.3390\/cancers12123796"},{"key":"8099_CR31","doi-asserted-by":"publisher","unstructured":"Khan A, Mostowy M, Owusu M, Mutambanengwe M, Habimana S, Bence S, et al. Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma. Exp Rev Gastroenterol Hepatol. 2020:1\u20135. https:\/\/doi.org\/10.1080\/17474124.2021.1869939.","DOI":"10.1080\/17474124.2021.1869939"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08099-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-08099-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08099-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T16:10:01Z","timestamp":1724775001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08099-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8099"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08099-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-139722\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"19 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University. All participants gave written informed consent for their data to be used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}